资讯

The group of experts gathered by the FDA unanimously voted on Tuesday, declaring ingredient phenylephrine to be no more effective than a placebo pill, according to review materials shared by the ...
If you pick a product containing phenylephrine, a common nasal decongestant, you might not get much relief. In fact, the FDA ...
“Modern studies, when well conducted, are not showing any improvement in congestion with phenylephrine,” said Dr. Mark Dykewicz, an allergy specialist at the Saint Louis University School of ...
Changes are coming to the cold and cough aisle of your local pharmacy: U.S. officials are moving to phase out the leading decongestant found in hundreds of over-the-counter medicines, concluding ...
Products with formulations that contain phenylephrine, the drug FDA experts deemed ineffective, make up about four-fifths of that market. The Consumer Healthcare Products Association maintains ...
Phenylephrine, a popular ingredient in many over-the-counter allergy and cold medicines, is ineffective in tablet form, an independent advisory committee to the US Food and Drug Administration ...
Pseudoephedrine and phenylephrine are both nasal decongestants but can have different side effects. You can only purchase pseudoephedrine from pharmacy staff and have to show your ID. You may know ...
It’s been one year since advisers to the Food and Drug Administration unanimously concluded that phenylephrine — a ...
US officials are moving to phase out phenylephrine, a decongestant found in products like Sudafed, concluding that it doesn't actually relieve nasal congestion. NY Post composite Changes are ...
The reason? An administration review found oral phenylephrine — a common ingredient in over-the-counter cold medications — doesn’t work. For some products, it is the only ingredient ...
Phenylephrine is used in popular versions of Sudafed, Dayquil and other medications, but experts have long questioned its effectiveness. Last month the Food and Drug Administration formally ...
Specifically, the FDA issued a proposed order to remove oral phenylephrine from the list of drugs that drugmakers can include in over-the-counter products—also known as the OTC monograph.